Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
about
Downregulation and growth inhibitory role of FHL1 in lung cancerMiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanismCancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.SRC induces podoplanin expression to promote cell migrationSDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.Src activates Abl to augment Robo1 expression in order to promote tumor cell migration.Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancerPlant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.SRC points the way to biomarkers and chemotherapeutic targets.Serum deprivation response inhibits breast cancer progression by blocking transforming growth factor-β signalingX-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.FHL1 interacts with oestrogen receptors and regulates breast cancer cell growthGenes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer.Cavin-2 in oral cancer: A potential predictor for tumor progression.Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.Fhl1 as a downstream target of Wnt signaling to promote myogenesis of C2C12 cells.Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.Down-regulation of the cavin family proteins in breast cancer.Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma.Downregulation and antiproliferative role of FHL3 in breast cancer.Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.IGF2-derived miR-483-3p associated with Hirschsprung's disease by targeting FHL1
P2860
Q24307767-2725B311-D65B-4E2B-AB23-5686F0565857Q27342777-09DDB3D8-51CB-4677-9851-73AC3F39FAD6Q33509293-C5A91B6D-D9A4-4FC5-B64B-6FAE8CA103DEQ33594999-6DF5F561-43BD-41CB-B352-463D17813524Q33744623-2DE54BCD-4498-4070-9EA0-E25742B2CC2CQ34507715-BE671626-CA03-42FB-A36A-84D788753405Q34683457-46F80E8F-D5A8-40C9-9E41-62DC6C0FE7E6Q34805223-07FED494-62D9-4115-9E59-AD0D0C1133F6Q36109632-57C875FA-B45D-4993-B7F9-A22E7463D695Q36443406-B52EA31D-70C2-4F20-B5A8-AF6AF0B91EFEQ36746259-52BC216F-F817-4E1E-B765-E417F86E2DEAQ37046664-61AD2799-6C8D-4911-8DE5-9FEEDFFE3BEAQ37110973-DDBEA0BB-CBB6-4F40-8996-D94A10DCF1CEQ37293773-CCA34BCC-9557-40CD-83C7-EF7386A934ACQ37294304-E076EF0B-1557-4F0B-A5FB-E8EC220534E6Q37595154-B2277402-9CB3-495B-9121-01AAFC4AC9BFQ38447860-6C118529-00DD-4525-AB07-08CBFAD6D0ECQ38862698-BF9385C7-FC07-4554-9DC5-7B588C85616CQ38892678-F750AB66-AF70-4CDD-B914-251A31C3C9F3Q39332945-17EB20F1-2A1A-4CD4-BFEF-B99304719A9FQ39389886-D458C16B-6B0A-466F-814E-8888630691CEQ39432750-0AAD2C41-CA76-449F-BDE7-71FD601461C7Q39474686-EC2A5088-C996-436C-BBDD-E86164CDDA80Q41016076-A066384D-991D-4196-B156-E54D8A53A6DCQ45877400-0DAB0DDE-D14A-44EA-BCC4-508B916497F3Q47129854-34C24A35-29B5-47AF-9E61-F427F7919189Q47254002-ADF1F73F-09E1-47B4-B8BC-2E8224838312Q50046229-8CC77073-D920-46DA-8301-D2F4F3105CFCQ58802653-F5217FCE-13DA-49D0-8845-23539FD9AC0E
P2860
Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@en
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@nl
type
label
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@en
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@nl
prefLabel
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@en
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@nl
P2093
P2860
P1433
P1476
Coordinate suppression of Sdpr ...... breast, kidney, and prostate.
@en
P2093
Gary S Goldberg
Hitoshi Ichikawa
Jonathan Jarvik
Robert G Nagele
Yongquan Shen
Zhenyu Jia
P2860
P304
P356
10.1111/J.1349-7006.2008.00816.X
P577
2008-04-15T00:00:00Z